{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:41:50Z","timestamp":1792564910242,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Special Research Project of Traditional Chinese Medicine in Henan Province","award":["2025LHZX2152"],"award-info":[{"award-number":["2025LHZX2152"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05448-y","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:51:19Z","timestamp":1792561879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zone-specific diagnostic performance of synthetic MRI quantitative parameters, ADC, and PSA density for clinically significant prostate cancer: comparison with PI-RADS v2.1"],"prefix":"10.1007","author":[{"given":"Yanan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7710-8492","authenticated-orcid":false,"given":"Tongming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"3","key":"5448_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5448_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86(2):148\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"issue":"2","key":"5448_CR3","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233337","volume":"312","author":"B Oerther","year":"2024","unstructured":"Oerther B, Nedelcu A, Engel H, Schmucker C, Schwarzer G, Brugger T et al (2024) Update on PI-RADS version 2.1 diagnostic performance benchmarks for prostate MRI: systematic review and meta-analysis. Radiology 312(2):e233337. https:\/\/doi.org\/10.1148\/radiol.233337","journal-title":"Radiology"},{"issue":"4","key":"5448_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10334-021-00957-6","volume":"35","author":"T Tamada","year":"2022","unstructured":"Tamada T, Ueda Y, Ueno Y, Kojima Y, Kido A, Yamamoto A (2022) Diffusion-weighted imaging in prostate cancer. MAGMA 35(4):533\u2013547. https:\/\/doi.org\/10.1007\/s10334-021-00957-6","journal-title":"MAGMA"},{"issue":"2","key":"5448_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.euo.2023.08.002","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang S, Kozarek J, Russell R, Drescher M, Khan A, Kundra V et al (2024) Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis. Eur Urol Oncol 7(2):189\u2013203. https:\/\/doi.org\/10.1016\/j.euo.2023.08.002","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"5448_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmri.27075","volume":"52","author":"Y Cui","year":"2020","unstructured":"Cui Y, Han S, Liu M, Wu PY, Zhang W, Zhang J et al (2020) Diagnosis and grading of prostate cancer by relaxation maps from synthetic MRI. J Magn Reson Imaging 52(2):552\u2013564. https:\/\/doi.org\/10.1002\/jmri.27075","journal-title":"J Magn Reson Imaging"},{"key":"5448_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2022.100403","author":"Y Arita","year":"2022","unstructured":"Arita Y, Akita H, Fujiwara H, Hashimoto M, Shigeta K, Kwee TC et al (2022) Synthetic magnetic resonance imaging for primary prostate cancer evaluation: diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements. Eur J Radiol Open. https:\/\/doi.org\/10.1016\/j.ejro.2022.100403","journal-title":"Eur J Radiol Open"},{"issue":"11","key":"5448_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/pros.24550","volume":"83","author":"H Cao","year":"2023","unstructured":"Cao H, Xu W, Xu Y, Rong X, Xiao X, Feng H et al (2023) Value of synthetic MRI quantitative parameters in preprocedural evaluation for TRUS\/MRI fusion-guided biopsy of the prostate. Prostate 83(11):1089\u20131098. https:\/\/doi.org\/10.1002\/pros.24550","journal-title":"Prostate"},{"issue":"10","key":"5448_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1177\/02841851251349488","volume":"66","author":"H Cheng","year":"2025","unstructured":"Cheng H, Yang B, Cui Y, Liu M, Zhang W, Wu B et al (2025) SyMRI histogram analysis for diagnosing clinically significant prostate cancer. Acta Radiol 66(10):1122\u20131131. https:\/\/doi.org\/10.1177\/02841851251349488","journal-title":"Acta Radiol"},{"key":"5448_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351:h5527. https:\/\/doi.org\/10.1136\/bmj.h5527","journal-title":"BMJ"},{"issue":"3","key":"5448_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76(3):340\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"key":"5448_CR12","doi-asserted-by":"publisher","unstructured":"van Leenders GJLH, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, et al. (2020) The 2019 International Society of Urological Pathology Consensus Conference on grading of prostatic carcinoma. Am J Surg Pathol. 44(8):e87-e99. https:\/\/doi.org\/10.1097\/PAS.0000000000001497.","DOI":"10.1097\/PAS.0000000000001497"},{"issue":"1","key":"5448_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jmri.27546","volume":"54","author":"KJ Park","year":"2021","unstructured":"Park KJ, Choi SH, Kim MH, Kim JK, Jeong IG (2021) Performance of Prostate Imaging Reporting and Data System Version 2.1 for diagnosis of prostate cancer: a systematic review and meta-analysis. J Magn Reson Imaging 54(1):103\u2013112. https:\/\/doi.org\/10.1002\/jmri.27546","journal-title":"J Magn Reson Imaging"},{"issue":"1131","key":"5448_CR14","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210509","volume":"95","author":"CH Lee","year":"2022","unstructured":"Lee CH, Vellayappan B, Tan CH (2022) Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis. Br J Radiol 95(1131):20210509. https:\/\/doi.org\/10.1259\/bjr.20210509","journal-title":"Br J Radiol"},{"key":"5448_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1013941","volume":"12","author":"J Wen","year":"2022","unstructured":"Wen J, Ji Y, Han J, Shen X, Qiu Y (2022) Inter-reader agreement of the prostate imaging reporting and data system version v2.1 for detection of prostate cancer: a systematic review and meta-analysis. Front Oncol 12:1013941. https:\/\/doi.org\/10.3389\/fonc.2022.1013941","journal-title":"Front Oncol"},{"issue":"5","key":"5448_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2214\/AJR.20.23883","volume":"216","author":"CG Wei","year":"2021","unstructured":"Wei CG, Zhang YY, Pan P, Chen T, Yu HC, Dai GC et al (2021) Diagnostic accuracy and interobserver agreement of PI-RADS Version 2 and Version 2.1 for the detection of transition zone prostate cancers. AJR Am J Roentgenol 216(5):1247\u20131256. https:\/\/doi.org\/10.2214\/AJR.20.23883","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"5448_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jmri.28061","volume":"56","author":"M Klingebiel","year":"2022","unstructured":"Klingebiel M, Schimm\u00f6ller L, Weiland E, Franiel T, Jannusch K, Kirchner J et al (2022) Value of T2 mapping MRI for prostate cancer detection and classification. J Magn Reson Imaging 56(2):413\u2013422. https:\/\/doi.org\/10.1002\/jmri.28061","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"5448_CR18","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.21037\/qims-24-291","volume":"14","author":"Z Gao","year":"2024","unstructured":"Gao Z, Xu X, Sun H, Li T, Ding W, Duan Y et al (2024) The value of synthetic magnetic resonance imaging in the diagnosis and assessment of prostate cancer aggressiveness. Quant Imaging Med Surg 14(8):5473\u20135489. https:\/\/doi.org\/10.21037\/qims-24-291","journal-title":"Quant Imaging Med Surg"},{"issue":"12","key":"5448_CR19","doi-asserted-by":"publisher","first-page":"9157","DOI":"10.21037\/qims-24-1014","volume":"14","author":"W Cao","year":"2024","unstructured":"Cao W, Lin J, Chen Y, Ling J, Meng T, Wen Z et al (2024) Cancer detection in patients with prostate-specific antigen levels within the grey zone: can synthetic magnetic resonance imaging aid in the differentiation between prostate cancer and noncancerous lesions? Quant Imaging Med Surg 14(12):9157\u20139168. https:\/\/doi.org\/10.21037\/qims-24-1014","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"5448_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/02841851251315717","volume":"66","author":"S Sirolu","year":"2025","unstructured":"Sirolu S, Seker ME, Alis D, Guroz B, Kayhan CK, Tokat F et al (2025) Assessing the aggressiveness of prostate cancer using ADC and relaxation maps from synthetic MRI. Acta Radiol 66(5):536\u2013545. https:\/\/doi.org\/10.1177\/02841851251315717","journal-title":"Acta Radiol"},{"key":"5448_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejro.2017.08.003","volume":"4","author":"J Bao","year":"2017","unstructured":"Bao J, Wang X, Hu C, Hou J, Dong F, Guo L (2017) Differentiation of prostate cancer lesions in the transition zone by diffusion-weighted MRI. Eur J Radiol Open 4:123\u2013128. https:\/\/doi.org\/10.1016\/j.ejro.2017.08.003","journal-title":"Eur J Radiol Open"},{"issue":"11","key":"5448_CR22","doi-asserted-by":"publisher","first-page":"846.e9","DOI":"10.1016\/j.urolonc.2020.05.024","volume":"38","author":"E Stevens","year":"2020","unstructured":"Stevens E, Truong M, Bullen JA, Ward RD, Purysko AS, Klein EA (2020) Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer. Urol Oncol 38(11):846.e9-846.e16. https:\/\/doi.org\/10.1016\/j.urolonc.2020.05.024","journal-title":"Urol Oncol"},{"issue":"11","key":"5448_CR23","doi-asserted-by":"publisher","first-page":"490.e1","DOI":"10.1016\/j.urolonc.2022.08.003","volume":"40","author":"J Drevik","year":"2022","unstructured":"Drevik J, Dalimov Z, Uzzo R, Danella J, Guzzo T, Belkoff L et al (2022) Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative. Urol Oncol 40(11):490.e1-490.e6. https:\/\/doi.org\/10.1016\/j.urolonc.2022.08.003","journal-title":"Urol Oncol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05448-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05448-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05448-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:51:20Z","timestamp":1792561880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05448-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":23,"alternative-id":["5448"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05448-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"10 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared that they have no conflicts of interest regarding this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Henan Provincial Hospital of Traditional Chinese Medicine (the Second Affiliated Hospital of Henan University of Chinese Medicine) (approval number: 1864\u201301). Due to the retrospective nature of the study and the use of anonymized data, the requirement for informed patient consent was waived by the Ethics Committee. Patient privacy was strictly protected throughout the study, and all data analyses were performed without disclosing personally identifiable information. All methods were carried out in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}